Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

IVD and pharma join forces in Portugal

This article was originally published in Clinica

Executive Summary

João Almeida Lopes has begun his tenure as president of Apifarma, Portugal’s industry association for the pharma and – now, also – the in vitro diagnostic (IVD) industries. His appointment is marked precisely by the association’s move to raise the profile of its IVD sector membership – which used to be represented in Apifarma only by a working group – as well as by the launch of a new strategy. The association’s “essential strategic themes” for 2013-14 are: access to diagnostic and therapeutic innovation; hospital debts to suppliers; and establishing “reasonable product cost-cutting targets”. His inaugural speech last week warned of the impact of cost-cutting on the Portuguese health system (www.clinica.co.uk, 9 April 2013), just as the country introduced a 15% across-the-board cut to the prices of diabetes supplies (www.clinica.co.uk, 9 April 2013).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT100212

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel